Novozymes surges yet again on Bioenergy
Novozymes reflects back on its fiscal 2022 as one of company’s better years. The Danish enzyme producer closes the period reporting full-year revenue of DKK 17.6bn (EUR 2.37bn). For comparison, the top-line post for 2021 totaled DKK 15bn.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novozymes to merge with Danish bioscience group
For subscribers
Novozymes overwhelmed by bioenergy's success
For subscribers